Figure 8 is titled “Standardized mean change from baseline to end of treatment in PTSD symptoms (CAPS) for exposure therapy compared with inactive comparator.” The figure displays a forest plot reporting the standardized mean difference in CAPS scores, exposure therapy versus inactive comparators. This figure is described further in the “PTSD symptoms” section as follows: “Our meta-analysis of the trials reporting CAPS scores found a greater decrease in PTSD symptoms among subjects treated with exposure than those in an inactive comparator group (SMD, −1.12; 95% CI, −1.42 to −0.82; 8 trials [9 comparisons], N=689); I-squared 68.66%; SOE) (Figure 8).”

Figure 8Standardized mean change from baseline to end of treatment in PTSD symptoms (CAPS) for exposure therapy compared with inactive comparator

CAPS = Clinician-Administered PTSD Scale; CI = confidence interval; PE = prolonged exposure; SMD = standardized mean difference; VRE = virtual reality exposure.

From: Results

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 207.
Forman-Hoffman V, Middleton JC, Feltner C, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.